BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32664747)

  • 1. The diagnostic value of postcontrast susceptibility-weighted imaging in the assessment of intracranial brain neoplasm at 3T.
    Kang H; Jang S
    Acta Radiol; 2021 Jun; 62(6):791-798. PubMed ID: 32664747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast medium enhanced susceptibility imaging signal mechanism; should we use contrast medium?
    Aydın Ö; Büyükkaya R; Hakyemez B
    Acta Radiol; 2017 Jan; 58(1):107-113. PubMed ID: 26966145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of contrast-enhanced SWI in patients with glioblastoma multiforme.
    Fahrendorf D; Schwindt W; Wölfer J; Jeibmann A; Kooijman H; Kugel H; Grauer O; Heindel W; Hesselmann V; Bink A
    Eur Radiol; 2013 Oct; 23(10):2868-79. PubMed ID: 23903995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precontrast and postcontrast susceptibility-weighted imaging in the assessment of intracranial brain neoplasms at 1.5 T.
    Hori M; Ishigame K; Kabasawa H; Kumagai H; Ikenaga S; Shiraga N; Aoki S; Araki T
    Jpn J Radiol; 2010 May; 28(4):299-304. PubMed ID: 20512548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility-Weighted Imaging of Glioma: Update on Current Imaging Status and Future Directions.
    Hsu CC; Watkins TW; Kwan GN; Haacke EM
    J Neuroimaging; 2016 Jul; 26(4):383-90. PubMed ID: 27227542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
    Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
    Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility-weighted imaging: the value in cerebral astrocytomas grading.
    Zhang H; Tan Y; Wang XC; Qing JB; Wang L; Wu XF; Zhang L; Liu QW
    Neurol India; 2013; 61(4):389-95. PubMed ID: 24005730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of gadobutrol versus gadopentetate dimeglumine in enhanced MRI of brain metastases.
    Fan B; Li M; Wang X; Xu Y; Li F; Zhang L; Jiang J; Jiang Y
    J Magn Reson Imaging; 2017 Jun; 45(6):1827-1834. PubMed ID: 27696616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations of ITSS-Morphology and their Relationship to Location and Tumor Volume in Patients with Glioblastoma.
    Fahrendorf D; Hesselmann V; Schwindt W; Wölfer J; Jeibmann A; Kooijman H; Kugel H; Heindel W; Bink A
    J Neuroimaging; 2015; 25(6):1015-22. PubMed ID: 25703027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution contrast-enhanced, susceptibility-weighted MR imaging at 3T in patients with brain tumors: correlation with positron-emission tomography and histopathologic findings.
    Pinker K; Noebauer-Huhmann IM; Stavrou I; Hoeftberger R; Szomolanyi P; Karanikas G; Weber M; Stadlbauer A; Knosp E; Friedrich K; Trattnig S
    AJNR Am J Neuroradiol; 2007 Aug; 28(7):1280-6. PubMed ID: 17698528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging.
    Park MJ; Kim HS; Jahng GH; Ryu CW; Park SM; Kim SY
    AJNR Am J Neuroradiol; 2009 Aug; 30(7):1402-8. PubMed ID: 19369602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility-weighted imaging of the brain: does gadolinium administration matter?
    El-Koussy M; Schenk P; Kiefer C; Osman OM; Mordasini P; Ozdoba C; Schroth G; Gönner F
    Eur J Radiol; 2012 Feb; 81(2):272-6. PubMed ID: 21216124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-parametric effect in predicting tumor histological grade by using susceptibility weighted magnetic resonance imaging in tongue squamous cell carcinoma.
    Yang X; Zhu J; Dai Y; Tian Z; Yang G; Shi H; Wu Y; Tao X
    BMC Med Imaging; 2019 Mar; 19(1):24. PubMed ID: 30866854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Susceptibility-Weighted Imaging (SWI) in the Detection of Brain Hemorrhagic Metastases from Breast Cancer and Melanoma.
    Franceschi AM; Moschos SJ; Anders CK; Glaubiger S; Collichio FA; Lee CB; Castillo M; Lee YZ
    J Comput Assist Tomogr; 2016; 40(5):803-5. PubMed ID: 27636126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery MRI for intracranial tumors in comparison with post-contrast T1W spin-echo MRI.
    Zhou ZR; Shen TZ; Chen XR; Peng WJ
    Chin Med J (Engl); 2006 Mar; 119(6):467-73. PubMed ID: 16584644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intergrating conventional MRI, texture analysis of dynamic contrast-enhanced MRI, and susceptibility weighted imaging for glioma grading.
    Su CQ; Lu SS; Han QY; Zhou MD; Hong XN
    Acta Radiol; 2019 Jun; 60(6):777-787. PubMed ID: 30244590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multilayer appearance on contrast-enhanced susceptibility-weighted images on patients with brain abscesses: Possible origins and effects of postprocessing.
    Chang HC; Chuang TC; Chung HW; Lin HS; Lai PH; Weng MJ; Fu JH; Wang PC; Li SC; Pan HB
    J Magn Reson Imaging; 2012 Dec; 36(6):1353-61. PubMed ID: 23097197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved motion-sensitized driven-equilibrium preparation for 3D turbo spin echo T1 weighted imaging after gadolinium administration for the detection of brain metastases on 3T MRI.
    Lee S; Park DW; Lee JY; Lee YJ; Kim T
    Br J Radiol; 2016 Jul; 89(1063):20150176. PubMed ID: 27187597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined value of susceptibility-weighted and perfusion-weighted imaging in assessing who grade for brain astrocytomas.
    Wang XC; Zhang H; Tan Y; Qin JB; Wu XF; Wang L; Zhang L
    J Magn Reson Imaging; 2014 Jun; 39(6):1569-74. PubMed ID: 24987755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive assessment of intratumoral vascularity using arterial spin labeling: A comparison to susceptibility-weighted imaging for the differentiation of primary cerebral lymphoma and glioblastoma.
    Furtner J; Schöpf V; Preusser M; Asenbaum U; Woitek R; Wöhrer A; Hainfellner JA; Wolfsberger S; Prayer D
    Eur J Radiol; 2014 May; 83(5):806-10. PubMed ID: 24613549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.